ロード中...
Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
BACKGROUND: To measure circulating anti-citrullinated peptide antibodies (ACPA) and cytokines pre- and 6 months post-therapy as a strategy to predict and optimize responses to traditional disease-modifying antirheumatic drugs (DMARDs) in early RA, which is an unmet need in developing countries. PATI...
保存先:
| 出版年: | BMC Musculoskelet Disord |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2015
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4446850/ https://ncbi.nlm.nih.gov/pubmed/26021985 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12891-015-0587-1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|